H1B Report
Side-by-side comparison

AstraZeneca Pharmaceuticals LP vs Microsoft Corporation

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
AstraZeneca Pharmaceuticals LP
DERank #FEIN 23-2967016
Entity B
Microsoft Corporation
WARank #5FEIN 91-1144442

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAstraZeneca Pharmaceuticals LPMicrosoft Corporation
Total filings75072,912
Certified %94.27%94.30%
Denied %1.60%0.15%
Withdrawn %1.60%0.69%
Cert-withdrawn %2.53%4.85%
Rank#5
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateDEWA

Outcomes — AstraZeneca Pharmaceuticals LP

DOL case-status mix.

Outcome breakdown: Certified 94.3%, Cert-withdrawn 2.5%, Withdrawn 1.6%, Denied 1.6%
Outcome breakdown
OutcomeShare
Certified94.3%
Cert-withdrawn2.5%
Withdrawn1.6%
Denied1.6%
Certified94.3%
Cert-withdrawn2.5%
Withdrawn1.6%
Denied1.6%

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.3%, Cert-withdrawn 4.9%, Withdrawn 0.7%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

AstraZeneca Pharmaceuticals LP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201113
FY20126
FY20136
FY201412
FY201527
FY201622
FY201726
FY201865
FY201944
FY202054
FY202185
FY202229
FY202339
FY2024107
FY2025136
FY202669
Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,407
FY20114,184
FY20124,005
FY20133,832
FY20143,674
FY20154,476
FY20164,919
FY20174,884
FY20185,457
FY20196,000
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20265,118

Top 5 occupations — AstraZeneca Pharmaceuticals LP

Top 5 occupations — Microsoft Corporation

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.